|
WO2020154533A1
|
|
Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
|
|
CA3036832A1
|
|
Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury
|
|
CN109219657A
|
|
Oligodendrocyte progenitor cells composition
|
|
AU2016308555A1
|
|
Stem cell-derived oligodendrocyte progenitor cells for the treatment of white matter stroke
|
|
AU2016206280A1
|
|
Hematopoietic cells from human embryonic stem cells
|
|
US2016331786A1
|
|
Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury
|
|
AU2015249110A1
|
|
Suspension culture of human embryonic stem cells
|
|
AU2015203433A1
|
|
Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
|
|
AU2014200013A1
|
|
Islet cells from human embryonic stem cells
|
|
AU2012258384A1
|
|
Hematopoietic cells from human embryonic stem cells
|
|
AU2012203350A1
|
|
Suspension culture of human embryonic stem cells
|
|
KR20160148065A
|
|
Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
|
|
EP2247718A1
|
|
Synthetic surfaces for culturing stem cell derived cardiomyocytes
|
|
EP2024492A2
|
|
Differentiation of primate pluripotent cells to hepatocyte-lineage cells
|
|
KR20160116024A
|
|
Suspension culture of human embryonic stem cells
|
|
AU2005271723A1
|
|
Medium for growing human embryonic stem cells
|
|
AU2005224670A1
|
|
Method for making high purity cardiomyocyte preparations suitable for regenerative medicine
|
|
AU2004214542A1
|
|
Neural progenitor cell populations
|
|
AU2004205307A1
|
|
Hepatocyte lineage cells derived from pluripotent stem cells
|
|
AU2004205306A1
|
|
Hepatocyte lineage cells derived from pluripotent stem cells
|
